An ongoing large clinical study (NCT03332225, a verification, and recovery experiment of immune dysfunction in patients with severe infection and sepsis) will further confirm the implication of IFN-γ in treating sepsis [147]. The gene discussed is IFNG; the disease is Sepsis.